Acute-on-chronic liver failure vs. traditional acute decompensation of cirrhosis
Author(s): ,
Richard Moreau
Affiliations:
Laboratoire d'Excellence (Labex) Inflamex, CUE Sorbonne Paris Cité, Paris, France
Thierry Gustot
Affiliations:
The EASL-CLIF Consortium, European Foundation-CLIF, Barcelona, Spain
Corresponding author. Address: Director of the Liver Transplant Unit, Dept. of Gastroenterology and Hepato-Pancreatology, C.U.B. Erasme. 808 route de Lennik, 1070 Brussels, Belgium. Tel.: +3225553714; fax: +3225554802.
EASL LiverTree™. Gustot T. Dec 1, 2018; 256779
Assoc. Prof. Thierry Gustot
Assoc. Prof. Thierry Gustot

Access to this content is an EASL members and LiverTree™ Privileged Users benefit.

Journal Abstract
References
Discussion Forum (0)
Rate & Comment (0)
This article does not have an abstract to display.Keyword(s)
Cirrhosis, Organ failure, Prognosis, Liver transplantation
[1]. G. D’Amico - New concepts on the clinical course and stratification of compensated and decompensated cirrhosis
[2]. V. Arvaniti - Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis
[3]. R. Jalan - Acute-on-chronic liver failure: pathophysiological basis of therapeutic options
[4]. S.K. Sarin - Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL)
[5]. R. Jalan - Role of predisposition, injury, response and organ failure in the prognosis of patients with acute-on-chronic liver failure: a prospective cohort study
[6]. R.K. Dhiman - Chronic Liver Failure-Sequential Organ Failure Assessment is better than the Asia-Pacific Association for the Study of Liver criteria for defining acute-on-chronic liver failure and predicting outcome
[7]. R. Moreau - Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis
[8]. J.S. Bajaj - Survival in infection-related acute-on-chronic liver failure is defined by extrahepatic organ failures
[9]. J.G. O’Leary - NACSELD Acute-on-Chronic Liver Failure (NACSELD-ACLF) Score Predicts 30-Day Survival in Hospitalized Patients with Cirrhosis
[10]. S. Piano - Association Between Grade of Acute on Chronic Liver Failure and Response to Terlipressin and Albumin in Patients With Hepatorenal Syndrome
[11]. T. Sersté - The prognostic value of acute-on-chronic liver failure during the course of severe alcoholic hepatitis
[12]. Y. Shi - Acute-on-chronic liver failure precipitated by hepatic injury is distinct from that precipitated by extrahepatic insults
[13]. H. Garg - Clinical profile and predictors of mortality in patients of acute-on-chronic liver failure
[14]. A. Choudhury - Liver failure determines the outcome in patients of acute-on-chronic liver failure (ACLF): comparison of APASL ACLF research consortium (AARC) and CLIF-SOFA models
[15]. J. Clària - Systemic inflammation in decompensated cirrhosis: characterization and role in acute-on-chronic liver failure
[16]. M. Bernardi - Mechanisms of decompensation and organ failure in cirrhosis: from peripheral arterial vasodilation to systemic inflammation hypothesis
[17]. H. Gomez - A unified theory of sepsis-induced acute kidney injury: inflammation, microcirculatory dysfunction, bioenergetics, and the tubular cell adaptation to injury
[18]. J.-M. Trawalé - The spectrum of renal lesions in patients with cirrhosis: a clinicopathological study
[19]. R. Moreau - The pathogenesis of ACLF: the inflammatory response and immune function
[20]. V. Arroyo - Acute-on-chronic liver failure in cirrhosis
[21]. R. Jalan - The CLIF Consortium Acute Decompensation score (CLIF-C ADs) for prognosis of hospitalised cirrhotic patients without acute-on-chronic liver failure
[22]. T. Gustot - Clinical Course of acute-on-chronic liver failure syndrome and effects on prognosis
[23]. R. Jalan - Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure
[24]. C.J. Karvellas - Dynamic prognostication in critically ill cirrhotic patients with multiorgan failure in ICUs in Europe and North America: a multicenter analysis
[25]. A.K. Choudhury - The decision for liver transplant in acute on chronic liver failure (ACLF) – first week is the crucial period – analysis of the APASL ACLF Research Consortium (AARC) prospective data of 1021 patients
[26]. M.K. Nadim - Management of the critically ill patient with cirrhosis: a multidisciplinary perspective
[27]. L.L. Gluud - Systematic review of randomized trials on vasoconstrictor drugs for hepatorenal syndrome
[28]. R. Bellomo - Intensity of continuous renal-replacement therapy in critically ill patients
[29]. J. Acevedo - Relative adrenal insufficiency in decompensated cirrhosis: relationship to short-term risk of severe sepsis, hepatorenal syndrome, and death
[30]. J. Fernández - Adrenal insufficiency in patients with cirrhosis and septic shock: effect of treatment with hydrocortisone on survival
[31]. A. Putignano - New concepts in acute-on-chronic liver failure: implications for liver transplantation
[32]. S.W. Biggins - Futility and rationing in liver retransplantation: when and how can we say no?
[33]. F. Artru - Liver transplantation in the most severely ill cirrhotic patients: a multicenter study in acute-on-chronic liver failure grade 3
[34]. B.-W. Duan - Liver transplantation in acute-on-chronic liver failure patients with high model for end-stage liver disease (MELD) scores: a single center experience of 100 consecutive cases
[35]. R. Bahirwani - Acute-on-chronic liver failure before liver transplantation: impact on posttransplant outcomes
[36]. R. Wiesner - Model for end-stage liver disease (MELD) and allocation of donor livers
[37]. W.R. Kim - Hyponatremia and mortality among patients on the liver-transplant waiting list
[38]. H.-Y. Sun - Impact of pretransplant infections on clinical outcomes of liver transplant recipients
[39]. K.-H. Lin - Impacts of pretransplant infections on clinical outcomes of patients with acute-on-chronic liver failure who received living-donor liver transplantation
[40]. V.R. Bertuzzo - Impact of preoperative infection on outcome after liver transplantation
[41]. P. Mathurin - Early liver transplantation for severe alcoholic hepatitis
[42]. G.Y. Im - Early liver transplantation for severe alcoholic hepatitis in the United States–a single-center experience
[43]. M.K. Nadim - Impact of the etiology of acute kidney injury on outcomes following liver transplantation: acute tubular necrosis versus hepatorenal syndrome
[44]. F. Wong - Outcomes of patients with cirrhosis and hepatorenal syndrome type 1 treated with liver transplantation
[45]. A.J. Slack - Ammonia clearance with haemofiltration in adults with liver disease
[46]. F.S. Cardoso - Continuous renal replacement therapy is associated with reduced serum ammonia levels and mortality in acute liver failure
[47]. R. Bañares - Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial
[48]. A. Kribben - Effects of fractionated plasma separation and adsorption on survival in patients with acute-on-chronic liver failure
[49]. W. Yue-Meng - The effect of plasma exchange on entecavir-treated chronic hepatitis B patients with hepatic de-compensation and acute-on-chronic liver failure
[50]. W. Mao - Prediction value of model for end-stage liver disease scoring system on prognosis in the acute on chronic liver failure patients with plasma exchange treatment
[51]. F.S. Larsen - High-volume plasma exchange in patients with acute liver failure: an open randomised controlled trial
[52]. V. Garg - Granulocyte colony-stimulating factor mobilizes CD34(+) cells and improves survival of patients with acute-on-chronic liver failure
[53]. X.-Z. Duan - Granulocyte-colony stimulating factor therapy improves survival in patients with hepatitis B virus-associated acute-on-chronic liver failure
[54]. M. Shi - Human mesenchymal stem cell transfusion is safe and improves liver function in acute-on-chronic liver failure patients
[55]. B.-L. Lin - Allogeneic bone marrow-derived mesenchymal stromal cells for hepatitis B virus-related acute-on-chronic liver failure: a randomized controlled trial
[56]. Y.-H. Li - Umbilical Cord-Derived Mesenchymal Stem Cell Transplantation in Hepatitis B Virus Related Acute-on-Chronic Liver Failure Treated with Plasma Exchange and Entecavir: a 24-Month Prospective Study
[57]. C.A. Philips - Healthy donor fecal microbiota transplantation in steroid-ineligible severe alcoholic hepatitis: a pilot study
Code of conduct/disclaimer available in General Terms & Conditions
Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.


Save Settings